By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Agios Pharmaceuticals 

38 Sidney Street
2nd Floor
Cambridge  Massachusetts  02139-4169  U.S.A.
Phone: 617-649-8600 Fax: n/a


SEARCH JOBS








Company News
Agios (AGIO) To Present Clinical And Preclinical Data At The 20th Congress Of The European Hematology Association 5/21/2015 12:24:45 PM
Agios (AGIO) Announces FDA Fast Track Designation Granted To AG-120 For Treatment Of Patients With Acute Myelogenous Leukemia With An IDH1 Mutation 5/18/2015 7:36:13 AM
Agios (AGIO) To Webcast Conference Call Of First Quarter 2015 Financial Results On May 7, 2015 4/29/2015 7:44:45 AM
Celgene (CELG) Dealmaking Continues With Two Pacts Worth $110 Million With Agios (AGIO), Northern Biologics 4/29/2015 6:59:38 AM
Agios Pharmaceuticals (AGIO) Announces Orphan Drug Designation Of AG-348 For Treatment Of Pyruvate Kinase Deficiency 3/24/2015 9:43:38 AM
Agios Pharmaceuticals (AGIO) To Present At Cowen and Company 35th Annual Health Care Conference On Monday, March 2 2/20/2015 7:51:29 AM
Agios Pharmaceuticals (AGIO) Reports Fourth Quarter And Full Year 2014 Financial Results 2/17/2015 7:36:08 AM
Agios Pharmaceuticals (AGIO) To Webcast Conference Call Of Fourth Quarter And Full Year 2014 Financial Results On February 17, 2015 2/10/2015 7:59:41 AM
Agios Pharmaceuticals (AGIO) To Present At The 2015 Leerink Global Healthcare Conference On Wednesday, February 11 2/3/2015 8:40:21 AM
Agios Pharmaceuticals (AGIO) Announces That Celgene (CELG) Has Agreed To Exercise Its Option To License AG-120 Under Global Strategic Collaboration 1/13/2015 6:57:53 AM
12345678910...
//-->